Prenatal genetics in a post-Roe United States
Published July 5, 2022
In June 2022, the Supreme Court removed a federal right to abortion access, returning the legality of abortion to each of the 50 states. This decision will have a profound impact on the provision of prenatal care in general and prenatal genetic screening and testing. Families, even those who do not want to terminate a pregnancy affected by a particular genetic trait, may find themselves under increased surveillance and suspicion throughout the pregnancy and beyond. And providers of reproductive healthcare, genetic test developers, and laboratories will need to gain familiarity with complex and shifting patchworks of legal restrictions.
Citation and link:
Allyse MA, Michie M. (2022) Prenatal genetics in a post-Roe United States. Cell Reports Medicine. https:// doi.org/10.1016/j.xcrm.2022.100690